PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
21.52%
Revenue growth exceeding 1.5x CRWD's 5.94%. David Dodd would verify if faster growth reflects superior business model.
78.69%
Cost growth above 1.5x CRWD's 7.31%. Michael Burry would check for structural cost disadvantages.
13.08%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
-6.95%
Both companies show margin pressure. Martin Whitman would check industry conditions.
5.02%
R&D growth 1.25-1.5x CRWD's 3.75%. Martin Whitman would scrutinize investment rationale.
-32.69%
G&A reduction while CRWD shows 7.72% growth. Joel Greenblatt would examine efficiency advantage.
38.25%
Marketing expense growth above 1.5x CRWD's 1.68%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
11.23%
Operating expenses growth above 1.5x CRWD's 3.48%. Michael Burry would check for inefficiency.
26.08%
Total costs growth above 1.5x CRWD's 4.38%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-1.28%
Both companies reducing D&A. Martin Whitman would check industry patterns.
15.10%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
-3.88%
Both companies show margin pressure. Martin Whitman would check industry conditions.
15.10%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
-5.28%
Operating margin decline while CRWD shows 14.45% growth. Joel Greenblatt would examine position.
-5.14%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
12.85%
Pre-tax income growth 50-75% of CRWD's 20.26%. Martin Whitman would scrutinize operations.
-7.13%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
5.17%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
16.30%
Net income growth 50-75% of CRWD's 29.52%. Martin Whitman would scrutinize operations.
-4.29%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
20.69%
EPS growth 50-75% of CRWD's 29.55%. Martin Whitman would scrutinize operations.
17.24%
Diluted EPS growth 50-75% of CRWD's 29.55%. Martin Whitman would scrutinize operations.
-1.27%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-1.24%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.